MedTrace Logo

Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee

NCT05737173 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2023-02-21

No results posted yet for this study

Summary

To compare the efficacy of intraarticular knee injection between leukocyte-rich and leukocyte-poor platelet-rich plasma in knee osteoarthritis treatment

Conditions

  • Osteo Arthritis Knee

Interventions

DRUG

Leukocyte-rich platelet-rich plasma

Intra-articular knee injection

DRUG

Leukocyte-poor platelet-rich plasma

Intra-articular knee injection

DRUG

Corticosteroid

Intra-articular knee injection

Sponsors & Collaborators

  • Queen Savang Vadhana Memorial Hospital, Thailand

    lead OTHER

Principal Investigators

  • Surapol Athiprayul, MD · Queen Savang Vadhana Memorial Hospital, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-03
Primary Completion
2022-09-01
Completion
2022-10-01

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05737173 on ClinicalTrials.gov